A platform for research: civil engineering, architecture and urbanism
A platform for research: civil engineering, architecture and urbanism
Neuronal Induction of Bone‐Fat Imbalance through Osteocyte Neuropeptide Y
A differentiation switch of bone marrow mesenchymal stem/stromal cells (BMSCs) from osteoblasts to adipocytes contributes to age‐ and menopause‐associated bone loss and marrow adiposity. Here it is found that osteocytes, the most abundant bone cells, promote adipogenesis and inhibit osteogenesis of BMSCs by secreting neuropeptide Y (NPY), whose expression increases with aging and osteoporosis. Deletion of NPY in osteocytes generates a high bone mass phenotype, and attenuates aging‐ and ovariectomy (OVX)‐induced bone‐fat imbalance in mice. Osteocyte NPY production is under the control of autonomic nervous system (ANS) and osteocyte NPY deletion blocks the ANS‐induced regulation of BMSC fate and bone‐fat balance. γ‐Oryzanol, a clinically used ANS regulator, significantly increases bone formation and reverses aging‐ and OVX‐induced osteocyte NPY overproduction and marrow adiposity in control mice, but not in mice lacking osteocyte NPY. The study suggests a new mode of neuronal control of bone metabolism through the ANS‐induced regulation of osteocyte NPY.
Neuronal Induction of Bone‐Fat Imbalance through Osteocyte Neuropeptide Y
A differentiation switch of bone marrow mesenchymal stem/stromal cells (BMSCs) from osteoblasts to adipocytes contributes to age‐ and menopause‐associated bone loss and marrow adiposity. Here it is found that osteocytes, the most abundant bone cells, promote adipogenesis and inhibit osteogenesis of BMSCs by secreting neuropeptide Y (NPY), whose expression increases with aging and osteoporosis. Deletion of NPY in osteocytes generates a high bone mass phenotype, and attenuates aging‐ and ovariectomy (OVX)‐induced bone‐fat imbalance in mice. Osteocyte NPY production is under the control of autonomic nervous system (ANS) and osteocyte NPY deletion blocks the ANS‐induced regulation of BMSC fate and bone‐fat balance. γ‐Oryzanol, a clinically used ANS regulator, significantly increases bone formation and reverses aging‐ and OVX‐induced osteocyte NPY overproduction and marrow adiposity in control mice, but not in mice lacking osteocyte NPY. The study suggests a new mode of neuronal control of bone metabolism through the ANS‐induced regulation of osteocyte NPY.
Neuronal Induction of Bone‐Fat Imbalance through Osteocyte Neuropeptide Y
Zhang, Yan (author) / Chen, Chun‐Yuan (author) / Liu, Yi‐Wei (author) / Rao, Shan‐Shan (author) / Tan, Yi‐Juan (author) / Qian, Yu‐Xuan (author) / Xia, Kun (author) / Huang, Jie (author) / Liu, Xi‐Xi (author) / Hong, Chun‐Gu (author)
Advanced Science ; 8
2021-12-01
20 pages
Article (Journal)
Electronic Resource
English
Neuronal Induction of Bone‐Fat Imbalance through Osteocyte Neuropeptide Y (Adv. Sci. 24/2021)
| Wiley | 2021
Intermittent Fasting Targets Osteocyte Neuropeptide Y to Relieve Osteoarthritis
| Wiley | 2024
Intermittent Fasting Targets Osteocyte Neuropeptide Y to Relieve Osteoarthritis
| Wiley | 2024
Sympathetic Innervation Regulates Osteocyte‐Mediated Cortical Bone Resorption during Lactation
| Wiley | 2023
Osteocyte lacunae features in different chicken bones
| British Library Conference Proceedings | 2009